JAMJOOM PHARMA

Jamjoom Pharmaceuticals Factory Co.

4015StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

1-5

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operations
Operating Cash Flow	406.29M	263.30M	295.92M	229.33M	228.70M
Free Cash Flow	353.25M	206.47M	250.74M	143.20M	101.90M
Capital Expenditures	-53.04M	-56.83M	-45.18M	-86.12M	-126.79M
Investing & Financing
Investing Cash Flow	-68.79M	-62.25M	-77.44M	-54.48M	-143.26M
Financing Cash Flow	-243.15M	-217.31M	-70.24M	-149.13M	-208.35M
Dividends Paid	-242.20M	-217.00M	-70.00M	-148.78M	-113.33M
Operating Activities
Operating Cash Flow	406.29M	263.30M	295.92M	229.33M	228.70M
Net Income	463.80M	356.52M	292.40M	171.31M	170.70M
Change in Accounts Payable	13.55M	20.93M	44.53M	-11.54M	-3.59M
Change in Accounts Receivable	-145.56M	-123.81M	18.03M	12.19M	46.74M
Change in Inventory	6.05M	-55.39M	-114.43M	-7.52M	-16.71M
Change in Other Net Operating Assets	3.60M	-6.57M	2.55M	-18.53M	—
Change in Working Capital	-122.36M	-164.85M	-49.32M	-25.39M	26.44M
Other Operating Activities	32.06M	36.83M	27.30M	54.79M	2.97M
Provision & Write-off of Bad Debts	2.42M	11.39M	2.10M	2.35M	2.25M
Depreciation & Amortization	43.45M	36.88M	26.15M	24.37M	24.08M
Other Amortization	635.36K	542.92K	476.31K	355.10K	269.06K
Cash Interest Paid	1.00M	21.74M	1.18M	13.23M	—
Loss (Gain) on Equity Investments	-13.84M	-18.57M	-4.41M	0.32M	—
Asset Writedown & Restructuring Costs	—	0.06M	—	—	—
Investing Activities
Investing Cash Flow	-68.79M	-62.25M	-77.44M	-54.48M	-143.26M
Capital Expenditures	-53.04M	-56.83M	-45.18M	-86.12M	-126.79M
Investment in Securities	—	-5.60M	-31.72M	33.02M	-19.08M
Other Investing Activities	-7.89M	—	—	—	2.48M
Sale (Purchase) of Intangibles	-7.87M	-0.17M	-0.60M	-1.53M	-0.02M
Sale of Property, Plant & Equipment	6.60K	339.01K	52.29K	148.37K	138.88K
Loss (Gain) From Sale of Assets	0.03M	-0.02M	1.26M	1.22M	-0.09M
Loss (Gain) on Sale of Investments	0.10M	4.52M	-0.04M	—	2.08M
Financing Activities
Financing Cash Flow	-243.15M	-217.31M	-70.24M	-149.13M	-208.35M
Common Dividends Paid	-242.20M	-217.00M	-70.00M	-148.78M	-113.33M
Long-Term Debt Issued	—	—	—	—	—
Long-Term Debt Repaid	-0.95M	-0.31M	-0.24M	-0.35M	-95.02M
Net Debt Issued (Repaid)	-0.95M	-0.31M	-0.24M	-0.35M	-95.02M
Free Cash Flow & Returns
Free Cash Flow	353.25M	206.47M	250.74M	143.20M	101.90M
Free Cash Flow Growth	+71.1%	-17.7%	+75.1%	+40.5%	-10.1%
Free Cash Flow Margin	+23.5%	+15.7%	+22.8%	+15.6%	+13.9%
Free Cash Flow Per Share	5.05	2.95	3.58	2.05	10.19
Levered Free Cash Flow	183.34M	95.31M	155.39M	84.13M	50.95M
Unlevered Free Cash Flow	183.46M	95.37M	155.46M	84.20M	50.95M
Operating Cash Flow Growth	+54.3%	-11.0%	+29.0%	+0.3%	-12.7%
Net Cash Flow	95.92M	-22.60M	143.09M	28.55M	-122.92M
Foreign Exchange Rate Adjustments	1.57M	-6.34M	-5.14M	2.83M	—

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

1-5

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operations
Operating Cash Flow	406.29M	263.30M	295.92M	229.33M	228.70M
Free Cash Flow	353.25M	206.47M	250.74M	143.20M	101.90M
Capital Expenditures	-53.04M	-56.83M	-45.18M	-86.12M	-126.79M
Investing & Financing
Investing Cash Flow	-68.79M	-62.25M	-77.44M	-54.48M	-143.26M
Financing Cash Flow	-243.15M	-217.31M	-70.24M	-149.13M	-208.35M
Dividends Paid	-242.20M	-217.00M	-70.00M	-148.78M	-113.33M
Operating Activities
Operating Cash Flow	406.29M	263.30M	295.92M	229.33M	228.70M
Net Income	463.80M	356.52M	292.40M	171.31M	170.70M
Change in Accounts Payable	13.55M	20.93M	44.53M	-11.54M	-3.59M
Change in Accounts Receivable	-145.56M	-123.81M	18.03M	12.19M	46.74M
Change in Inventory	6.05M	-55.39M	-114.43M	-7.52M	-16.71M
Change in Other Net Operating Assets	3.60M	-6.57M	2.55M	-18.53M	—
Change in Working Capital	-122.36M	-164.85M	-49.32M	-25.39M	26.44M
Other Operating Activities	32.06M	36.83M	27.30M	54.79M	2.97M
Provision & Write-off of Bad Debts	2.42M	11.39M	2.10M	2.35M	2.25M
Depreciation & Amortization	43.45M	36.88M	26.15M	24.37M	24.08M
Other Amortization	635.36K	542.92K	476.31K	355.10K	269.06K
Cash Interest Paid	1.00M	21.74M	1.18M	13.23M	—
Loss (Gain) on Equity Investments	-13.84M	-18.57M	-4.41M	0.32M	—
Asset Writedown & Restructuring Costs	—	0.06M	—	—	—
Investing Activities
Investing Cash Flow	-68.79M	-62.25M	-77.44M	-54.48M	-143.26M
Capital Expenditures	-53.04M	-56.83M	-45.18M	-86.12M	-126.79M
Investment in Securities	—	-5.60M	-31.72M	33.02M	-19.08M
Other Investing Activities	-7.89M	—	—	—	2.48M
Sale (Purchase) of Intangibles	-7.87M	-0.17M	-0.60M	-1.53M	-0.02M
Sale of Property, Plant & Equipment	6.60K	339.01K	52.29K	148.37K	138.88K
Loss (Gain) From Sale of Assets	0.03M	-0.02M	1.26M	1.22M	-0.09M
Loss (Gain) on Sale of Investments	0.10M	4.52M	-0.04M	—	2.08M
Financing Activities
Financing Cash Flow	-243.15M	-217.31M	-70.24M	-149.13M	-208.35M
Common Dividends Paid	-242.20M	-217.00M	-70.00M	-148.78M	-113.33M
Long-Term Debt Issued	—	—	—	—	—
Long-Term Debt Repaid	-0.95M	-0.31M	-0.24M	-0.35M	-95.02M
Net Debt Issued (Repaid)	-0.95M	-0.31M	-0.24M	-0.35M	-95.02M
Free Cash Flow & Returns
Free Cash Flow	353.25M	206.47M	250.74M	143.20M	101.90M
Free Cash Flow Growth	+71.1%	-17.7%	+75.1%	+40.5%	-10.1%
Free Cash Flow Margin	+23.5%	+15.7%	+22.8%	+15.6%	+13.9%
Free Cash Flow Per Share	5.05	2.95	3.58	2.05	10.19
Levered Free Cash Flow	183.34M	95.31M	155.39M	84.13M	50.95M
Unlevered Free Cash Flow	183.46M	95.37M	155.46M	84.20M	50.95M
Operating Cash Flow Growth	+54.3%	-11.0%	+29.0%	+0.3%	-12.7%
Net Cash Flow	95.92M	-22.60M	143.09M	28.55M	-122.92M
Foreign Exchange Rate Adjustments	1.57M	-6.34M	-5.14M	2.83M	—